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The intestinal mucus barrier prevents pathogen inva-
sion and maintains host-microbiota homeostasis.
We show that fatty acid synthase (FAS), an insulin-
responsive enzyme essential for de novo lipogen-
esis, helps maintain the mucus barrier by regulating
Mucin 2, the dominant mucin in the colon and
a central component of mucus. Inducible Cre recom-
binase-directed inactivation of the FAS gene in the
colonic epithelium of mice is associated with disrup-
tions in the intestinal mucus barrier as well as
increased intestinal permeability, colitis, systemic
inflammation, and changes in gut microbial ecology.
FAS deficiency blocked the generation of palmitoy-
lated Mucin 2, which must be S-palmitoylated at its
N terminus for proper secretion and function.
Furthermore, a diabetic mouse model exhibited
lower FAS levels and a decreased mucus layer,
which could be restored with insulin treatment.
Thus, the role of FAS in maintaining intestinal barrier
function may explain the pathogenesis of intestinal
inflammation in diabetes and other disorders.
INTRODUCTION
Critical functions such as programming of the immune system
and processing of nutrients are impacted by the commensal
relationship between a mammalian host and its intestinal micro-
biota (Kau et al., 2011; Macpherson and Harris, 2004). This rela-
tionship is predicated on the ability of the host to restrict bacteria
to the lumen of the intestine. Separation of host and bacteria
depends on humoral and physical barriers. The former consists
of IgA, a-defensins, lysozymes, lectins such as RegIIIg (Vaish-
nava et al., 2011), and other antimicrobial factors (McGuckin
et al., 2011). The latter consists of the intestinal epithelium and
its overlying mucus, a component of which is normally sterile
(Johansson et al., 2008). The relationship between the mucus
barrier and the microbiota is dynamic. Goblet cells, the source140 Cell Host & Microbe 11, 140–152, February 16, 2012 ª2012 Elseof mucus, are decreased in germfree mice (Kandori et al.,
1996), genes involved in mucus secretion are regulated by the
microbiota (Comelli et al., 2008), and products of bacterial
fermentation such as butyrate increase colonic mucus synthesis
(Finnie et al., 1995). These observations indicate that the resident
microbiota affects the biology of the mucus barrier.
Surprisingly, there is relatively little information regarding the
effect of pathogens on the mucus barrier. Rotavirus infection in
mice increases production of the most abundant gel-forming
component of mucus, Mucin 2 (Muc2), and results in mucins
capable of neutralizing rotavirus in vitro (Boshuizen et al.,
2005). Also in mice, changes in mucus production and composi-
tion appear to facilitate clearance of the parasites G. seoi (Guk
et al., 2009) and T. muris (Hasnain et al., 2011). While our under-
standing of the impact of pathogens on the mucus barrier during
infection is limited, even less is known about how factors intrinsic
to the host may affect the integrity of the mucus barrier and
promote infection.
One host factor important for maintaining homeostasis in
several tissues is de novo lipogenesis, which involves the
conversion of simple precursors into fat. In mammals, this
process requires fatty acid synthase (FAS), a multifunctional
protein that synthesizes saturated fatty acids for cell
membranes, energy stores, and signaling molecules (Lodhi
et al., 2011; Wakil, 1989). FAS expression is induced by insulin,
in part through transcriptional mechanisms that include
SREBP-1c and LXRa (Wong and Sul, 2010). Diabetes is
frequently associated with gastrointestinal complications (Sellin
and Chang, 2008), including increased gut permeability reflect-
ing colonic as well as small intestinal abnormalities (Bosi et al.,
2006; Meddings et al., 1999). Mechanisms underlying these
abnormalities and the effects of the diabetic state on interactions
between the human gut microbiota and host remain poorly
understood.
Increased epithelial permeability can precede the develop-
ment of chronic intestinal inflammation (Olson et al., 2006).
Serum levels of endotoxin are elevated in humans with both
type 1 and type 2 diabetes (Creely et al., 2007; Devaraj et al.,
2009) suggesting disruption of homeostasis that normally exists
between the microbiota and host and that is required for main-
taining gut integrity. Host-microbial interactions in the gut, in
turn, can be markedly impacted by the loss of integrity of thevier Inc.
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Figure 1. Intestine-Specific Deletion of FAS in FAS-Villin Mice
(A) Left panel: Western blotting of FAS and actin in intestinal extracts from tamoxifen-treated villin-Cre mice (without floxed FAS alleles), tamoxifen-treated FAS
floxed mice (without villin-Cre), tamoxifen-treated FAS villin-Cre mice (with both floxed FAS alleles and villin-Cre), and from vehicle-treated FAS villin-Cre mice.
Right panel: Western blotting of FAS and actin in brain, lung, liver, spleen, and fat recovered from FAS floxed (FASf/f) and FAS-villin (with both floxed FAS alleles
and villin-Cre) mice following tamoxifen treatment.
(B) Upper panel: Western blotting of FAS and actin in colon from FAS-villin animals at various time points after tamoxifen treatment. Bottom panel: q-RT-PCR for
intestinal FAS expression in control (C) or FAS-villin mice on days 3–9 after initiation of tamoxifen treatment (n = 3 per condition, data presented as mean ± SEM).
White indicates control, while red indicates tamoxifen treatment.
(C) Confirmation of intestinal deletion of FAS in FAS-villinmice by immunocytochemistry. The first and third rows show FAS immunostaining (green) in jejunum and
colon of control and FAS-villin mice after tamoxifen treatment. The second and fourth rows show DAPI staining (blue). Scale bars: 50 mm. (Also see Figure S1.)
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Fatty Acid Synthase and Intestinal Integritymucosal barrier (Garrett et al., 2010). To understand how gut
lipogenesis affects intestinal physiology, including barrier
function, we used an inducible Cre recombinase driven by the
intestine-specific villin promoter to inactivate FAS in the gut
epithelium of 6- to 8-week-old mice.
RESULTS
Intestinal FAS Deficiency Initiates Inflammation
Tamoxifen induction of Cre recombinase for 5 days decreased
intestinal FAS protein, mRNA, and tissue staining in adult (6- to
8-week-old) mice hemizygous for the Cre transgene and homo-
zygous for the floxed FAS allele (villin-Cre-ER:FASf/f; abbreviatedCell Host &FAS-villin), but not in control mice homozygous for the floxed
allele but lacking the Cre transgene (FASf/f) (Figures 1A and
1B). Decreased FAS expression was noted along the length of
the intestine, but was most prominent in the distal small intestine
and colon, where FAS expression is normally highest (Figures 1B
and 1C). Intestinal FAS expression was unaffected in vehicle-
treated FAS-villin mice. Moreover, no diminution in FAS was
noted in the liver, fat, lung, brain, or spleen of tamoxifen-treated
FAS-villin mice compared to control mice (Figure 1A, right
panels).
Tamoxifen-induced deletion of intestinal FAS in FAS-villin
mice was associated with a statistically significant decrement
in body weight that did not occur in (i) FAS-villin mice treatedMicrobe 11, 140–152, February 16, 2012 ª2012 Elsevier Inc. 141
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Figure 2. Intestinal Phenotype of FAS-Villin Mice
(A and B) (A) Mean (±SEM) body weights and (B) survival in mice with inducible inactivation of FAS in the gut. Littermates in a series of experiments received
injections of tamoxifen or vehicle on days 1–5. FAS-villin (FAS floxed alleles with villin-Cre) + tamoxifen, n = 46; FAS floxed (without Cre) + tamoxifen, n = 28;
FAS-villin + vehicle, n = 7; FAS floxed + vehicle, n = 4, villin-Cre (without FAS floxed) + tamoxifen, n = 9. For the survival curve, the control symbol represents
a composite of all the control groups since there were no deaths in any controls. FAS-villin symbols represent FAS-villin mice treated with tamoxifen on days 1–5.
p < 0.01 for survival by logrank testing.
(C) In vivo detection of orally administered tracer (10 kDa dextran). Representative imaging is shown on the left and quantitation of fluorescent imaging (presented
as pixels detected over a standard area of the abdomen) on the right. *p < 0.01 (with data presented as mean ± SEM) by two-tailed unpaired t test for 12 control
and 14 FAS-villin mice.
(D–F) (D) TNFa (25 control and 15 FAS-villin mice), (E) endotoxin (31 control and 23 FAS-villin mice), and (F) LBP (27mice for each condition) serum levels assayed
on day 9 as denoted in (A). *p < 0.01 (with data presented as mean ± SEM) by two-tailed unpaired t test.
(G andH) (G) Levels of secreted cytokines and (H)MPO activity from colons (5 control and 4 FAS-villin) 9 days after initiation of tamoxifen injections. Mean values ±
SEM are plotted with p values shown or *p < 0.05 by two-tailed unpaired t test.
(I) Histology scores (mean ± SEM) for the ceca of 6 control and 8 FAS-villin mice. (Also see Figure S2.)
Cell Host & Microbe
Fatty Acid Synthase and Intestinal Integritywith vehicle alone, (ii) Cre transgenicmice without the floxed FAS
allele treated with tamoxifen, (iii) FAS floxedmice without the Cre
transgene treated with vehicle, or (iv) FAS floxed mice without
the Cre transgene treated with tamoxifen (Figure 2A). This weight
loss was evident after 5 days of tamoxifen treatment, progressed
over the ensuing 9 days, and then slowly resolved, a time course
mirroring the normal period required to a complete a cycle of
epithelial renewal. Weight loss was associated with statistically
significant decreases in adipose tissue, food intake (Figures
S1A–S1C), fasting serum glucose, triglycerides, and free fatty
acids (Figures S1D– S1F). Twenty percent of FAS-villin animals142 Cell Host & Microbe 11, 140–152, February 16, 2012 ª2012 Elsedied within 14 days after induction of Cre expression, compared
to none in all of the control groups (n = 46 and 48 animals,
respectively) (Figure 2B).
Imaging live mice after oral administration of labeled dextran
revealed that deletion of FAS resulted in disruption of intestinal
barrier integrity: fluorescence in the intestinal lumen was dimin-
ished (due to increased absorption of the usually impermeable
tracer) in FAS-villin mice as compared to controls (p < 0.01; t
test; n = 12 FAS floxed controls and 14 FAS-villin mice) (Fig-
ure 2C). In a confirmatory assay, circulating concentrations of
FITC-labeled dextran (both 4 kDa and 40 kDa species invier Inc.
Cell Host & Microbe
Fatty Acid Synthase and Intestinal Integrityindependent experiments) after gavage were significantly higher
in FAS-villin animals (p < 0.01; t test; n = 13 control and 9
FAS-villin for FD4 [FITC dextran 4 kDa]; n = 15 control and 12
FAS-villin for FD40 [FITC dextran 40 kDa]) (Figures S2A and
S2B). Consistent with increased access of intestinal contents
to the systemic circulation, serum levels of TNFa, endotoxin,
and LBP (lipopolysaccharide-binding protein) were elevated in
FAS-villin mice (Figures 2D–2F).
The macroscopic appearance of large intestinal contents was
altered (Figure S2C) and fecal wet/dry ratio was increased (p <
0.01; t test; n = 7 control and 12 FAS-villin) (Figure S2D), suggest-
ing a diarrheal syndrome in FAS-villin mice. There was loss of
crypts in the ileum and cecum of FAS-villin mice (quantified in
Figure S2E). Tissue ELISA assays showed statistically significant
increases in TNFa and IL-1b in the colons of FAS-villin animals
(Figure 2G). MPO activity was significantly increased in FAS-villin
colons (Figure 2H). The FAS-villin colonic lamina propria was
infiltrated with significantly more mononuclear cells as deter-
mined by FACS (Figure S2F); these results were confirmed by
CD11b and MOMA staining (not shown, n = 3–4 animals per
condition). Blinded histological scores demonstrated signifi-
cantly increased inflammation in the cecum (Figure 2I). The
same trend was observed in the colon (Figure S2G). tnfa expres-
sion was increased in the distal small intestine, but other
biomarkers of inflammation were not (data not shown).
Apoptosis, detected by TUNEL staining (Figure S2H) and
confirmed by caspase-3 staining (data not shown), was signifi-
cantly increased in FAS-villin colons, as was proliferation, de-
tected by Ki67 staining (Figure S2I) and BrdU (data not shown).
b-catenin, part of the Wnt signaling pathway intimately involved
in epithelial barrier function and intestinal proliferation, was acti-
vated to a greater extent in FAS-villin colons (data not shown).
These findings suggest a hyperplastic response characteristic
of repair following injury to the mucosal barrier (van der Flier
and Clevers, 2009).
FAS-Villin Microbiota Fail to Transfer the Inflammatory
Phenotype to Germfree Mice
Pyrosequencing variable region 2 (V2) of bacterial 16S rRNA
genes present in the cecal microbiota harvested from conven-
tionally raised, tamoxifen-treated, FAS-villin and control mice
consuming a standard polysaccharide-rich, low fat chow diet
(n = 5–7 animals/group; 2419 ± 495 reads /sample) (Table S1)
disclosed that loss of FAS did not have a statistically significant
effect on alpha diversity (overall richness as measured using the
Chao1 estimator and observed number of species-level phylo-
types). Beta-diversity analyses (between sample comparisons)
revealed that loss of FAS was accompanied by modest, albeit
statistically significant, differences in the representation of class
level taxa belonging the Firmicutes, Bacteroidetes, and Proteo-
bacteria phyla (Table S1). Principal coordinates analysis
(PCoA), based on pairwise comparisons of UniFrac distances
between fecal bacterial communities, failed to show significant
clustering based on host genotype (UniFrac measures the over-
all degree of phylogenetic relatedness of communities based on
the degree to which they share branch length on a bacterial tree
of life). Differences in class-level taxonomic representation were
not maintained when cecal microbiota from FAS-villin mice and
control animals were transplanted into 8-week-old wild-typeCell Host &germfree C57BL/6J recipients for 2 weeks (n = 6 mice/group;
1158 ± 674 denoised V2 16S rRNA reads/sample).
Furthermore, transplantation of cecal microbiota pooled from
multiple FAS-villin or control donors into multiple adult germfree
wild-type C57BL/6J mice resulted in no differences in body
weights, body composition, or intestinal histology between the
two groups of recipient animals at the end of the 2-week interval
(Figures 3A–3C). Together, these findings suggest that changes
in gut microbial ecology accompanying conditional FAS gene
knockout in the distal intestinal epithelium were a response to,
rather than a cause of, observed changes in the structure and
function of the mucosal barrier.
Antibiotic Treatment Ameliorates the Inflammatory
Phenotype of FAS-Villin Mice
Administration of ciprofloxacin (9.9 mg/kg) and metronidazole
(37.5 mg/kg), by daily oral gavage beginning at the time of
tamoxifen induction of Cre expression, resulted in significantly
less weight loss in FAS-villin as compared to control mice (Fig-
ure 3D). Antibiotic treatment corrected the increased wet/dry
ratio of feces (Figure 3E), normalized serum endotoxin (Fig-
ure 3F), and significantly decreased serum TNFa concentrations
(Figure 3G) in FAS-villin mice. These findings suggest that the gut
microbiota contributes to the inflammatory state induced by FAS
depletion.
Intestinal FAS Deficiency Decreases Muc2 and Disrupts
the Inner Mucus Layer
One interpretation of these results is that the FAS-villin pheno-
type is caused by a cell-autonomous process operating at the
level of the intestinal epithelium. While the number of enteroen-
docrine cells and absorptive enterocytes (detected by chromog-
ranin A and alkaline phosphatase staining, respectively) (Figures
4A and 4B) were minimally affected in the colons of FAS-villin
animals, Alcian blue staining for mucus was dramatically
decreased, suggesting a defect in the third colonic epithelial
lineage, namely, mucin-producing goblet cells (Figure 4C).
The mucus blanket overlying the intestinal epithelium consists
of an inner stratified layer that is tightly adherent to epithelial cells
and an outer unattached layer. These two layers are organized
into a netlike polymer aroundMucin2 (Muc2), the most abundant
mucin protein, which is heavily glycosylated and secreted by
goblet cells (Johansson et al., 2011). Mucus thickness varies
along the length of the gut, is greatest in the colon (Johansson
et al., 2011), and is modulated by the microbiota (Comelli
et al., 2008).
Muc2 levels were decreased in the colons of FAS-villin versus
control mice, as assessed by immunocytochemistry (Figure 4D).
Colonic Muc2 mRNA levels were also significantly lower in FAS-
villin mice (p < 0.05, t test; n = 5 animals per group) (Figure 4E).
Expression of another secreted goblet cell protein associated
with the mucosa, trefoil factor 3 (Tff3), was not significantly
different between FAS conditional knockout mice and controls
(Figure 4F), suggesting that loss of FAS produced selective
defects in protein secretion by this epithelial lineage. Decreased
Muc2 expression was associated with a significant decrease in
the average thickness of the inner stratified mucus layer in the
colons of fasted FAS-villin as compared to fasted control mice
(Figures 4G and 4H). Dual-label immunocytochemistry usingMicrobe 11, 140–152, February 16, 2012 ª2012 Elsevier Inc. 143
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Figure 3. Microbiota Transplantation Does Not Transfer but Antibiotic Treatment Ameliorates the FAS-Villin Phenotype
(A) Weight of donor mice following initiation of tamoxifen treatment on day 1.
(B) Weight of recipient germfree mice.
(C) Body composition of recipient germfree mice.
(D–G) (D) Body weight, (E) feces wet/dry ratio, (F) serum endotoxin, and (G) serum TNFa in control and FAS-villin mice with and without daily antibiotic treatment.
p values are shown or *p < 0.05. Data are presented as mean ± SEM. (Also see Table S1.)
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Fatty Acid Synthase and Intestinal Integritya Muc2 antibody and the lectin Dolichos Biflorus Agglutinin
(DBA; carbohydrate specificity alpha-linked N-acetylgalactos-
amine), which recognizes Muc2 due to its extensive O-glycosyl-
ation (Johansson et al., 2008), further confirmed loss of normal
Muc2 in FAS-villin mice (Figure 4I). CEACAM1, a pleotropic
adhesion molecule involved in epithelial function and immunity,
is found in Muc2-containing mucus layers (Johansson et al.,
2008) and has been implicated in regulation of FAS (Najjar
et al., 2005). Ceacam1 expression was decreased in the colon
(by 30%) and ileum (by 45%) of FAS-villin mice compared
to control mice (each p < 0.05; two-tailed unpaired t test; n = 4
control and n = 5 FAS-villin).
FAS Is Required for Normal Muc2 Secretion
To identify a potential molecular link between FAS and mucin
biogenesis, we replicated the effect of FAS deficiency on Muc2
in cultured cells. Muc2 protein was significantly decreased in
extracts prepared from colons of FAS-villin mice (Figure 5A),
and decreased among the proteins secreted from LS174T cells144 Cell Host & Microbe 11, 140–152, February 16, 2012 ª2012 Else(a colon carcinoma cell line) after lentivirus-mediated shRNA
knockdown of FAS (Figure 5B). Since the Muc2 N terminus is
involved in its secretion (Godl et al., 2002), we expressed the
HA-tagged N terminus of Muc2 (N-Muc2; residues 1–300) in
COS cells. Little is known about the structural domains required
for normal secretion of Muc2, but using our expression system in
these cells, an intact protein of the expected size (38 kDa) as
well as a band likely representing a dimer (76 kDa) were
detected in cell lysates (Figure 5C). Only the dimer was detected
in supernatants indicating secretion of this form. No shorter frag-
ments were detected with the anti-HA antibody, and there was
no evidence of cell death or lysis as judged by morphology.
Knockdown of FAS expression in N-Muc2-expressing cells
impaired N-Muc2 secretion (Figure 5C; note the decrease in
dimeric N-Muc2 in the supernatant fraction of FAS knockdown
cells). Conversely, overexpression of FAS in the COS cells
increased N-Muc2 secretion (Figure 5D). Thus, FAS appears to
be involved in Muc2 secretion and this effect can be modeled
in cultured cells.vier Inc.
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Figure 4. Muc2 Levels Are Reduced and the Inner Mucus Layer Disrupted in the Colons of FAS-Villin Mice
(A) Staining for chromogranin A (which detectsmost enteroendocrine cells) and (B) alkaline phosphatase (biomarker of the enterocytic lineage) in colons of control
(FAS floxed animals without Cre treated with tamoxifen) or FAS-villin (FAS floxed animals with villin-Cre treated with tamoxifen) mice.
(C) Alcian blue staining (to detect goblet cells) in mouse colon.
(D) Muc2 immunostaining in mouse colon.
(E) mRNA levels for Muc2 and (F) Tff3 in mouse colon at days 7 and 9 as denoted in Figure 2A (n = 5 per condition; mean values ± SEM are plotted; *p < 0.05 by
t test).
(G) Disruption of the colonic mucus layer in FAS-villin mice detected by Muc2 immunocytochemistry. The white dashed lines denote the epithelial cell surface
while the yellow dashed lines indicate the lumenal border of the inner mucus layer.
(H) Average thickness of the inner mucus layer measured at the proximal colon. Measurements were made perpendicular to the inner mucus layer at 5–7 different
sites for each colon. Data represent thickness determinations for 5 mice per condition. Mean values ± SEM are plotted. *p < 0.05 (t test).
(I) Merged images of Muc2 (red) and DBA (green) staining in the colons of control and FAS-villin mice. Scale bar: 50 mm. (Also see Figure S3.)
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Fatty Acid Synthase and Intestinal IntegrityThe major product of FAS is palmitate, which is converted to
palmitoyl-CoA, the substrate for DHHC palmitoyl transferases.
These membrane-associated transferases catalyze the revers-
ible posttranslational linkage of palmitate via a thioester bond
to cysteines on a variety of proteins (Greaves and Chamberlain,
2011). FAS from silkworms can carry out S-palmitoylation of
synthetic peptides (Ueno and Suzuki, 1997), and FAS is involved
in Wnt-1 S-palmitoylation in prostate cancer cells (Fiorentino
et al., 2008) as well as eNOS S-palmitoylation in endothelial
cells (Wei et al., 2011). To determine if the Muc2 N terminus is
S-palmitoylated, COS cells transfected with N-Muc2 were sub-Cell Host &jected to a biotin switch assay for S-palmitoylation (Wan et al.,
2007). With this technique, free thiols are chemically blocked
with N-ethylmaleimide, hydroxylamine is used to cleave thio-
ester bonds at palmitoylation sites, these sites are biotinylated,
and the biotinylated protein is affinity-captured and detected
by western blotting. N-Muc2 showed a hydroxylamine-depen-
dent signal in the biotin switch assay (Figure 5E), indicating
S-palmitoylation. Sequence analysis of the Muc2 N terminus re-
vealed potential sites for S-palmitoylation: Cys12, Cys163, and
Cys166 (Figure 5F). When Cys12 was mutated to Ser (Figure 5G,
C12S), N-Muc2 dimer formation was blocked but the monomerMicrobe 11, 140–152, February 16, 2012 ª2012 Elsevier Inc. 145
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Figure 5. FAS-Dependent S-Palmitoylation Is Required for Normal Muc2 Secretion
(A) Muc2 protein content assayed by ELISA (mean ± SEM) in colon extracts from mice at day 7 as denoted in Figure 2A.
(B) Muc2 protein content (mean ± SEM) secreted from LS174T cells following lentivirus-mediated shRNA knockdown of FAS. Verification of the knockdown is
shown by western blotting in the bottom panels.
(C) The HA-taggedMuc2 N terminus (N-Muc2) was expressed in COS7 cells, which were treated with a control (scrambled) or FAS-specific siRNA. The top panel
shows western blotting with an antibody to FAS, and the bottom panels blotting with an anti-HA antibody.
(D) HA-tagged FAS was overexpressed in COS cells using a retrovirus, then N-Muc2 was expressed in the same cells. The top panel verifies expression of the
tagged FAS. The bottom panels show western blotting of N-Muc2, distinguished from FAS by differences in protein size.
(E) Biotin switch assay demonstrates S-palmitoylation of N-Muc2 by detecting a biotin moiety that is hydroxylamine (NH2OH)-dependent.
(F) Sequence alignment of human, mouse, and rat N-Muc2 with the conserved Cys12 residue (mouse) indicated in green and the conserved Cys163 and Cys166
residues (mouse) indicated in yellow.
(G) Western blotting of lysates or culture supernatants for N-Muc2 mutants.
(H) Biotin switch assay using wild-type N-Muc2 and N-Muc2 mutants.
(I) Biotin switch assay for N-Muc2 S-palmitoylation in control (scrambled) and FAS knockdown cells. (Also see Figure S4.)
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Fatty Acid Synthase and Intestinal Integritywas secreted normally (Figure 5G, lower panel, compare C12S
andWT lanes). Mutation of Cys163 or Cys166 to Ser, or mutation
of both residues to Ser abolished secretion (Figure 5G). In palmi-
toylation assays, signal was diminished when either Cys163 or
Cys166 was mutated to Ser (Figure 5H, only C166S is shown)
suggesting decreased palmitoylation. When both sites were
mutated (C163S, C166S), N-Muc2 palmitoylationwas essentially
abolished (Figure 5H). Note that the palmitoylation assay detects
lipid modification in cell extracts, and that decreased S-palmi-
toylation due to loss of the thiol group at either Cys163 or
Cys166 is capable of blocking protein secretion (Figures 5G
and 5H). S-palmitoylated N-Muc2 (detected in extracts treated
with hydroxylamine) is strikingly decreased when FAS was
knocked down (Figure 5I). In concert with our finding that FAS146 Cell Host & Microbe 11, 140–152, February 16, 2012 ª2012 Elseknockdown also impairs Muc2 secretion (Figures 5B and 5C),
these results suggest that FAS-dependent S-palmitoylation of
Muc2 is required for its normal secretion.
Impaired Muc2 secretion induced by loss of FAS could be
associated with ER stress. When assayed prior to the develop-
ment of the systemic inflammatory phenotype, mRNAs for
XBP1s/u and CHOP were significantly increased in mouse
colons (Figure S3A). FAS knockdown in LS174T cells was asso-
ciated with significantly increased mRNA levels for GRP78,
CHOP, and XBP1s/u (Figure S3B), suggesting that ER stress
might contribute to the inflammation of FAS-villin mice.
Since several tight junction proteins are S-palmitoylated, it is
possible that part of the impaired barrier function phenotype is
mediated by mucin-independent effects. There was no overtvier Inc.
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judged by immunocytochemistry (n = 3 mice per condition)
(Figures S3C and S3D). Claudins are major functional determi-
nants of the epithelial tight junction barrier, and palmitoylation
of claudin-14 in a kidney cell line is required for its proper local-
ization in tight junctions (Van Itallie et al., 2005). Claudin-1 protein
levels were decreased in the colons of FAS-villin as compared to
control mice as assessed by immunocytochemistry (n = 3 mice
per condition) (Figure S4A, top); decreased claudin-1 protein
staining was also seen in the colons of Muc2 deficient mice
(n = 3 mice per condition) (Figure S4A, bottom). These findings
are consistent with a recent report that claudin-1 mRNA is
decreased in the colons of Muc2 knockout mice in the setting
of colonic inflammation (Lu et al., 2011). However, when FAS
was knocked down in Caco-2 cells, there was no major effect
on claudin-1 S-palmitoylation as determined by the biotin-switch
assay (Figure S4B), and claudin-1 protein was not decreased as
assessed by immunocytochemistry (Figure S4C). Collectively,
these results suggest that FAS deficiency does not affect clau-
din-1 S-palmitoylation or claudin protein directly, but may affect
claudin-1 levels in the colon in vivo due to chronic inflammation
induced by disruption of Muc2 function.
Diabetic Mice Have an Intestinal Phenotype Mimicking
FAS-Villin Mice
Since FAS is induced by insulin and the intestinal mucus layer is
decreased in diabetic rodents (Igarashi et al., 2000), we as-
sessed FAS expression in mice with experimental diabetes.
Compared to relevant controls, colonic FAS protein content
was significantly lower in two diabetes models: C57BL/6 mice
treated with streptozotocin (STZ) and transgenic C57BL/6 mice
with engineered expression of an ATP-insensitive KATP channel
(Kir6.2) in pancreatic beta-cells (Remedi et al., 2009) (Figure 6A).
Circulating concentrations of FITC-labeled dextran after gavage
(the same assay used to study FAS-villin mice) (Figure S2A) were
significantly higher in STZ-treated animals (Figure 6B). The
average thickness of the inner stratified mucus layer was
decreased in the colons of STZ-treated as compared to control
mice (Figures 6C and 6D), and the colonic epithelium of STZ-
treated mice was infiltrated with more inflammatory cells as
compared to controls (n = 4 mice per condition) (Figure S4).
These results demonstrate that intestinal barrier function is dis-
rupted in experimental diabetes, mimicking effects seen in
FAS-villin mice.
Analogous to FAS-villin mice, STZ-treated mice manifested
decreased goblet cell staining. The inner mucus layer (Figure 6E,
arrow) was clearly identified in controls but not in STZ-treated
mice, suggestive of a defect in Muc2 with insulin deficiency.
The inner, tightly adherent mucus layer prevents bacteria from
accessing the epithelium (Johansson et al., 2011). Staining with
a fluorescent probe for bacteria (Johansson et al., 2008) showed
the presence of bacteria deep within the intestinal epithelium in
FAS-villin mice (arrows in Figure 6F), while bacteria were limited
to the lumen by the intact mucus gel layer in controls (three mice
surveyed/treatment group). The same stain in control and STZ-
treated mice showed a discrete clear layer separating bacteria
and mucosal epithelium in control mice (Figure 6G, double-
headed arrow on left): this layer was disrupted in STZ-treated
mice and accompanied by the presence of bacteria deep withinCell Host &the epithelium (Figure 6G, arrows). Disruption of the mucus
barrier and penetration of bacteria into the epithelium in FAS-
villin are consistent with increased intestinal permeability and
increased circulating levels of TNFa, LPS, and LBP in these
animals.
To determine if the increased permeability of mice with dia-
betes can be reversed by insulin, C57BL/6 mice were injected
with STZ (Figure 7A, day 0) to induce diabetes then implanted
with pumps delivering either saline or insulin (Figure 7A, day 3).
Glucose levels in mice fed ad libitum (Figure 7A) were signifi-
cantly lower in those that were insulin-treated compared to
saline-treated from days 4–12. Fasting glucose levels were
also significantly decreased with insulin (data not shown). Of
note, insulin therapy improved but did not normalize the glucose
phenotype of the diabetic mice. At day 12, colonic FAS protein
was decreased in saline-infused mice but increased in insulin-
infused mice (Figure 7B). Insulin treatment significantly
increased body weight (Figure 7C). As seen with another cohort
of STZ-diabetic mice (Figure 6D), diabetes decreased inner
mucus layer thickness (Figure 7D). Insulin treatment increased
the thickness of this layer, as shown in Figure 7D (p = 0.05).
The results of Alcian blue staining of colons from control nondi-
abetic, saline-infused diabetic, and insulin-infused diabetic mice
are presented in Figure 7E, with the inner mucus layer denoted
by arrows. Insulin treatment significantly decreased circulating
FD4 (FITC dextran 4 kDa) in diabetic mice (Figure 7F), and this
value was not significantly different from controls, indicating
that insulin corrected the permeability phenotype in this diabetes
model.DISCUSSION
Our findings suggest that the insulin-regulated enzyme FAS
modifies mucosal barrier integrity in intestinal epithelial cells, in
part by affectingMuc2 lipidation, and that this effect is accompa-
nied by changes in mucosal barrier function. While we acknowl-
edge that FAS could also be affecting other aspects of intestinal
biology, our observation linking FAS andMuc2 identifies a poten-
tially important element in the multifaceted regulation of the
intestinal mucus layer (Johansson et al., 2011). FAS deficiency
impaired Muc2 secretion and was associated with decreased
goblet cell Muc2. FAS-villin mice bear a striking resemblance
to mice with missense mutations in Muc2 (Heazlewood et al.,
2008). These mutations are also associated with decreased
Muc2 in the setting of defective secretion, suggesting that accu-
mulation of Muc2 might promote its degradation or accelerate
goblet cell loss. Muc2 mutant mice, like FAS-villin mice, have
a defective mucus barrier, increased intestinal permeability,
enhanced inflammation, and colitis. Evidence of ER stress
accompanies the phenotype in both models.
Mice genetically deficient in Muc2 eventually develop colo-
rectal cancers (Velcich et al., 2002): they are missing the inner
adherent mucus layer and, as with FAS-villin mice, bacteria
penetrate deep into the colonic epithelium of these animals
(Johansson et al., 2008) to promote inflammation. Since intes-
tinal FAS expression as well as mucus thickness is greatest in
the colon, and FAS deficiency caused by genetic manipulation
or insulin deficiency is associated with a defective inner mucusMicrobe 11, 140–152, February 16, 2012 ª2012 Elsevier Inc. 147
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Figure 6. Mice with Experimental Diabetes Have Phenotypic Features that Resemble Those of Mice with Conditional Deletion of FAS in
the Gut
(A) Western blotting for FAS and actin in colon extracts from diabetic mice. For panels on the top, streptozotocin (STZ) or vehicle (control) was injected into
C57BL/6 male mice. For panels on the bottom, nondiabetic mice with no expression of a mutant Kir6.2 and hyperglycemic mice with overexpression of a mutant
Kir6.2 induced by RIP-Cre were studied.
(B) Serum fluorescence (expressed as relative fluorescence units or RFUs, mean ± SEM) following gavage of mice with FITC-dextran (4 kDa).
(C) Detection of disruption of the inner mucus layer by anti-Muc2 staining in STZ-treated mice. The white dashed lines mark the epithelial cell surface, while the
yellow dashed lines identify the lumenal border of the inner mucus layer.
(D) Colons were fixed in methanol-Carnoy fixative without disruption of fecal contents following by determination of the thickness of the inner mucus layer.
Measurements were made perpendicular to the inner mucus layer at 5–7 different sites for each colon. Data represent thickness determinations for 6–7 mice per
condition. Mean values ± SEM are plotted. *p < 0.05 (t test).
(E) Alcian blue staining for mucus-producing goblet cells in the colons of control or STZ mice. The arrow indicates the inner adherent mucus layer.
(F) Fluorescent in situ hybridization for bacteria (red) in colon fromwild-type and FAS-villin mice. Nuclei are stained with DAPI. As expected, bacteria are detected
by red color in the lumen, but arrows denote bacterial penetration of the epithelium in FAS-villin colon.
(G) Fluorescent hybridization of bacteria in colon from control or STZmice. The double-headed arrow identifies a clear space separating bacteria and epithelium
in control mice. Single arrows denote bacterial penetration into crypts in STZ mice. Scale bars: 50 mm. (Also see Figure S5.)
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lating the intestinal mucus barrier.
FAS expression is decreased in the ileum and colon of humans
with ulcerative colitis (Heimerl et al., 2006). Evidence linking
FAS and human inflammatory bowel disease is limited. Our find-
ings in mice could prompt speculation that FAS-mediated
effects on Muc2 might exacerbate inflammation in humans.
Moreover, FAS is induced by insulin, and there are reports148 Cell Host & Microbe 11, 140–152, February 16, 2012 ª2012 Elsethat hyperinsulinemia is associated with protection from clinical
relapse in patients with inflammatory bowel disease (Valentini
et al., 2009).
Diabetes as well as obesity and themetabolic syndromemight
be impacted by the insulin-FAS-Muc2 axis in the intestine. The
microbiota is involved in diabetes syndromes in mice (Vijay-
Kumar et al., 2010; Wen et al., 2008), although alterations in
microbial composition in metabolic disorders tend to be morevier Inc.
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Figure 7. Correction of the Intestinal Permeability Defect by Insulin in Experimental Diabetes
(A) Glucose levels in mice injected with STZ on day 0 (solid arrow), then implanted with pumps delivering saline or insulin (7 mice per condition) on day 3
(open arrow).
(B) Western blotting of FAS protein in colons of mice at day 12.
(C) Body weight of treated mice.
(D) Inner mucus layer thickness for control (n = 4), saline-treated diabetic mice (STZ+saline, n = 7), and insulin-treated diabetic mice (STZ+insulin, n = 7).
(E) Alcian blue images from the animals shown in (D).
(F) Intestinal permeability assay of animals after gavage with FD4 (n = 5 for nondiabetic controls and n = 7 for each diabetic group). P values are shown or *p < 0.05
(data presented as mean ± SEM).
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Diabetes and the metabolic syndrome represent chronic
inflammatory states characterized by activation of systemic
and cell-autonomous inflammatory pathways (Shoelson et al.,
2006). It is not known if these pathways are modulated by FAS
through its effects on host-microbial interactions in human dia-
betes syndromes. It is also not known if different microbial
community structures can affect host FAS. However, our work
raises the possibility that an alteration in the host, namely
decreased barrier function due to altered FAS, facilitates micro-
bial access to promote inflammation.
Both type 1 and type 2 diabetes require pancreatic beta
cell dysfunction manifested as insufficient insulin secretion to
control glucose metabolism. Colonic lymph drains to pancreatic
lymph nodes in mice (Carter and Collins, 1974), suggesting
a plausible framework to explain how disruption of intestinalCell Host &FAS could contribute to the diabetic state. This notion is
supported by recent data showing that endotoxemia, presum-
ably due to increased intestinal permeability, is associated
with the development of diabetes independent of risk factors
such as obesity, lipids, and C-reactive protein (Pussinen et al.,
2011).
In summary, the insulin-responsive enzyme FAS in intestinal
epithelial cells affects mucosal barrier function in mice by lipi-
dating Muc2. Considerable additional work will be required to
implicate FAS modulation of host-microbial interactions in the
pathophysiology of metabolic diseases. This may include identi-
fying strategies that promote lipogenesis to preserve Muc2
acylation or that inhibit Muc2 deacylation. Testing the impact
of these strategies in models characterized by mucosal barrier
dysfunction and chronic inflammation could lead to novel thera-
pies for diabetes syndromes.Microbe 11, 140–152, February 16, 2012 ª2012 Elsevier Inc. 149
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Animal Models
The Washington University Animal Studies Committee approved protocols.
Mice with inactivation of FAS in the intestine (FAS-villin mice) were generated
by crossing floxed FAS mice (Chakravarthy et al., 2005) with villin-Cre-ERT2
mice (el Marjou et al., 2004). Littermates of mixed genetic background at
6–8 weeks of age were used for experiments that included administering
tamoxifen (1 mg per mouse) or vehicle for 5 consecutive days as described
(el Marjou et al., 2004). To induce diabetes, streptozotocin (150 mg/kg) or
vehicle was administered to 2-month-old C57BL/6J male mice, and diabetic
animals were studied in the setting of a serum glucose > 300 mg/dl 1 week
later. Hyperglycemic mice carrying an ATP-insensitive mutant KATP channel
in beta cells and control Rosa-Kir6.2 mice were a gift from Colin Nichols
(Remedi et al., 2009). Muc2 null mice and wild-type controls each in the
C57BL/6J background were studied at 3 months of age.
Bacterial 16S rRNA Analyses and Microbiota Transplants
Details of methods and analysis for microbiota sequencing are provided in
Supplemental Information. For microbiota transfer experiments, cecal
contents were recovered from conventionally raised FAS-villin mice 9 days
after initiation of a 5-day treatment period with tamoxifen or vehicle. Methods
for gavage of harvested communities into germfree 8-week-old C57BL/6J
mice (n = 6 donor samples pooled from the control group and n = 9 donor
samples pooled from FAS-villin mice; each pooled sample introduced into 6
recipients) are described (Turnbaugh et al., 2006). All donors and all recipients
were fed the same plant polysaccharide-rich/low fat chow diet (B&K Universal,
Ltd.). Fourteen days after transplant, recipient gnotobiotic mice were sub-
jected to the phenotypic assays described in the main text, then sacrificed,
and their cecal contents were removed for 16S rRNA-based analyses.
Intestinal Permeability Assays
Mice were gavaged with dextran (4 kDa or 40 kDa) conjugated to fluorescein
isothiocyanate (Sigma), then sacrificed 4 hr later, and their serum was
collected for fluorescence measurements (490 nm excitation/520 nm emis-
sion). Fluorescence detection in living, anesthetized mice was captured with
a Carestream In-Vivo Imaging System FX Pro system (Kodak). Fluorescent
conjugated dextran (10 kDa with Alexa Fluor 680) was gavaged into mice,
and then animals were studied 1 hr later using multispectral fluorescent
capture (450 nm to 630 nm excitation with 700 nm emission) followed by digital
X-ray imaging. Nonspecific background signals were removed, and mice not
subjected to gavage were included in experimental runs. The fluorescent
intensity of the dye after gavage was calculated using software provided by
the manufacturer and the results corrected by subtraction of signal measured
in mice not subjected to gavage.
Cytokine ELISA and Myeloperoxidase Activity Assay
Colons were flushed with PBS to remove lumenal contents, opened, and
washed three times by gentle agitation in HBSS with antibiotics (15 min for
each wash), then minced into small pieces and transferred to 24-well plates
with growth media containing antibiotics. After a 24-hr incubation, the super-
natants were collected and subjected to ELISAs for several cytokines, accord-
ing to the instructions provided by the manufacturer (TNFa and Interferon g,
BD Bioscience; IL-17, IL-1b, and IL12p40, R&D Systems).
For themyeloperoxidase activity assay, tissueswere homogenized in a solu-
tion of 0.5% hexadecyltrimethyl ammonium bromide in 50 mM potassium
phosphate buffer (pH 6.0), subjected to three rapid freeze-thaw cycles, and
then centrifuged at 4C to remove insoluble material. The MPO containing
supernatant (0.1 ml) was assayed after addition of 2.88 ml phosphate buffer
containing 0.167 mg/ml o-dianisidine hydrochloride (Sigma) and 0.0005%
hydrogen peroxide. The kinetics of absorbance changes at 450 nm (37C)
were measured as MPO activity and results were normalized by protein
concentrations.
Histological Scoring
Hematoxylin and eosin stained slides were scored by observers unaware of
the animal genotype based on a known assessment system (Rachmilewitz
et al., 2002) as follows. (A) Depth/degree of ulcer: 0, no ulcer; 1, mucosal150 Cell Host & Microbe 11, 140–152, February 16, 2012 ª2012 Elseinvolvement; 2, mucosal-submucosal involvement; 3, invasion of the mus-
cularis propria; 4, full thickness penetration. (B) Extent of ulcer: 0, no ulcer; 1,
punctate, <10%; 2, minimal, 10%–25%; 3, moderate, 26%–50%; 4,
widespread, >50%. (C) Degree of inflammation: 0, none; 1, mucosal,
increased cellularity between crypts, crypt almost normal; 2, mucosal +
submucosal involvement, moderate cellullar increase, distorted crypts <
50%; 3, mucosa+submucosal +inflammatory infiltrate in the muscularis
propria, large increase in cellularity, distorted crypts > 50%; 4, full thickness
involvement, loss of all crypts. (D) Extent of inflammation (fraction of the width
of a single 103 field): 0, none; 1, minimal, <25%; 2, mild, 25%–50%; 3,
moderate, 51%–75%; 4, severe, >75%. (E) Degree of edema (width of the
clear space in the muscularis mucosa): 0, none; 1, minimal, width < 13; 2,
mild, 13–23; 3, moderate, >23–33; 4, severe, >33. (F) Extent of edema: 0,
none; 1, minimal, <25%; 2, mild, 25%–50%; 3, moderate, 51%–75%; 4,
severe, >75%.
FACS Analysis
Colons were isolated and washed as described above for ELISA assays. Cell
suspensions from the lamina propria were obtained by mincing tissues into
small pieces, followed by digestion using collagenase (1 mg/ml, Worthington),
dispase I (1 mg/ml, Invitrogen) and DNase I (50 mg/ml, Roche). After red blood
cell lysis using an RBC lysis buffer (eBioscience), filtered cells were counted
and identified by FACS using antibodies (eBioscience) against CD11b and
F/80 (PE, BM8).
Assays for Protein S-Palmitoylation
A biotin switch assay (Wan et al., 2007) was modified to detect S-acylation of
Muc2. Cells were homogenized in lysis buffer (150 mM NaCl, 50 mM Tris
[pH 7.4], 5 mM EDTA) in the presence of 20 mM NEM, sonicated on ice,
then Triton X-100 (1.7%) was added, and the mixture was rotated in a cold
room. Samples were treated with chloroform/methanol (1:4), solubilized in
4% SDS with 20 mM NEM at 37C for 3 hr, and subjected to serial protein
precipitations to remove residual NEM. Each sample was then aliquoted to
two tubes and resuspended in buffer containing HPDP-biotin (1 mM) and
Triton X-100 (0.2%) in the presence or absence of hydroxylamine (NH2OH).
After 1 hr, proteins were precipitated twice with chloroform/methanol and
solubilized in buffer containing 0.1% SDS, streptavidin-agarose beads were
added, the mixture was incubated for 1.5 hr at room temperature, then
biotin-labeled proteins were detected by western blotting.
Insulin Treatment of Diabetic Mice
Following administration of streptozotocin (STZ, 150 mg/kg) or vehicle as
described above in 2-month-old C57BL/6 male mice, diabetic animals were
implanted with micro-osmotic pumps (Alzet, model 1004) containing either
saline or insulin (5 mU per kg of body weight per day). Mice were divided
into three groups: vehicle injection (nondiabetic control group); STZ injection
with implantation of pump infusing a saline solution; and STZ injection with
implantation of pump infusing an insulin solution.
Statistics
Data are expressed as mean ± SEM except as indicated. The two-tailed
unpaired t test was used for most comparisons except for survival curves,
which were compared using the logrank test.
Details of methods used for histology and immunohistology, serum assays,
quantitative RT-PCR, Muc2 manipulations, and generating and analyzing
metagenomic (bacterial 16S rRNA) data sets are provided in Supplemental
Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.chom.2011.12.006.
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